Literature DB >> 482585

Systemic lupus with nephritis: a long-term study.

J S Cameron, D R Turner, C S Ogg, D G Williams, M H Lessof, C Chantler, S Leibowitz.   

Abstract

Seventy-one patients with systemic lupus erythematosus and clinical evidence of nephritis were seen during a 15-year period, and followed for a mean of seven years. Survival was calculated to be 76 per cent at five years and 57 per cent at ten years from onset of clinical nephritis; and 80, 65, 55 and 55 per cent five, ten, fifteen and twenty years from onset of clinical lupus. Renal biopsies showed mild or focal lesions in 30 per cent of patients, membranous lesions in 14 per cent and diffuse proliferative lesions in 55 per cent. However, there was no difference in the long-term outcome of the different histological groups. Nineteen patients (27 per cent) died during follow up, eleven from renal failure, six from sepsis and two from cerebral lupus. Death in renal failure is now usually a late event in lupus, even in patients with clinical evidence of severe nephritis. The prognosis of even severe lupus nephritis is now better than formerly reported. Reducing the dose of corticosteroid drugs, by the use of cytotoxic drugs such as azathioprine may have diminished the mortality from cardiovascular complications. Side effects of treatment, however, remain an important cause of death and morbidity.

Entities:  

Mesh:

Year:  1979        PMID: 482585

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  22 in total

1.  Cross-reaction of anti-DNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis.

Authors:  Hui Du; Min Chen; Ying Zhang; Ming-Hui Zhao; Hai-Yan Wang
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  Relation between serological data at the time of biopsy and renal histology in lupus nephritis.

Authors:  J C Nossent; S C Henzen-Logmans; T M Vroom; V Huysen; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

3.  Rheumatoid factor in patients with systemic lupus erythematosus.

Authors:  A Zoli; L Altomonte; R Caricchio; A Galossi; L Mirone; F Scuderi; M Magaro
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

Review 4.  Treatment of systemic lupus erythematosus.

Authors:  P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

Review 5.  Renal vasculitis: a review.

Authors:  G Neild
Journal:  J R Soc Med       Date:  1985-08       Impact factor: 5.344

Review 6.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

Review 7.  Immunosuppressive therapy in the treatment of autoimmune diseases.

Authors:  P A Miescher; P Beris
Journal:  Springer Semin Immunopathol       Date:  1984

8.  Thrombosis in systemic lupus erythematosus.

Authors:  A C Leung
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-26

Review 9.  The treatment of lupus nephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

10.  DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus.

Authors:  D Adu; J Dobson; D G Williams
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.